
==== Front
BMJ OpenBMJ OpenbmjopenbmjopenBMJ Open2044-6055BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR bmjopen-2016-015645corr110.1136/bmjopen-2016-015645corr1Miscellaneous1506Correction: Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy 2017 22 12 2017 7 12 e015645corr1© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.2017This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/special-featureunlocked
==== Body
Restelli U, Saibene G, Nardulli P, et al. Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy. BMJ Open 2017;7:e015645. doi: 10.1136/bmjopen-2016-015645.

There is an error in Supplementary file 1. In the first table of the supplementary material, Annex 1, in row MEC, −2.5 and −4.4 in column ‘Δ NEPA – APR+PALO (%)’ should be +2.5 and +4.4, respectively.

